<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03182062</url>
  </required_header>
  <id_info>
    <org_study_id>iPROVE-OLV</org_study_id>
    <nct_id>NCT03182062</nct_id>
  </id_info>
  <brief_title>Individualized Perioperative Open-Lung Ventilatory Strategy During One-Lung Ventilation</brief_title>
  <acronym>iPROVE-OLV</acronym>
  <official_title>Postoperative Complication and Hospital Stay Reduction With a Individualized Perioperative Lung Protective Ventilation During One-lung Ventilation: A Prospective, Multicenter, Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación para la Investigación del Hospital Clínico de Valencia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación para la Investigación del Hospital Clínico de Valencia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether individualized ventilatory management
      during one-lung ventilation in patients scheduled for thoracic surgery, combining the use of
      low tidal volumes, alveolar recruitment maneuvers, individually titrated positive
      end-expiratory pressure and individually indicated ventilatory support will decrease
      postoperative pulmonary complications, ICU and hospital length of stay compared to a
      standardized Lung Protective Ventilation (LPV).
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2018</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of postoperative pulmonary complications</measure>
    <time_frame>Up to 7 postoperative days</time_frame>
    <description>composite of pulmonary infection, severe respiratory failure, acute respiratory distress syndrome, pneumothorax, bronchopleural fistula, atelectasis requiring bronchoscopy, empyema.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction of composite of postoperative pulmonary complications</measure>
    <time_frame>Up to 30 postoperative days</time_frame>
    <description>suspicion of pulmonary infection, mild acute respiratory failure, severe respiratory failure, acute respiratory distress syndrome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of composite of postoperative complications</measure>
    <time_frame>Up to 7 and 30 postoperative days</time_frame>
    <description>Renal failure, cardiac failure, sepsis, septic shock, surgical site infection, urinary infection and other pulmonary complications not included in the primary outcome such as leaks, atelectasis, pleural effusion, empyema, dyspnea.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensive care unit and hospital length of stay reduction</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1400</enrollment>
  <condition>Thoraric Surgery</condition>
  <condition>Surgery Time Expected More Than Two Hours</condition>
  <arm_group>
    <arm_group_label>OLA-iHFNC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intraoperatively ventilated patients with a tidal volume (VT) of 5-6ml / kg of ideal body weight and respiratory rate to maintain normal carbon dioxide. After intubation, in all patients will be performed an alveolar recruitment maneuver (MRA) and a PEEP titration trial (see Calculation of optimal PEEP). Every 40 minutes will be assessed the need to adjust the level of PEEP by evaluating the dynamic compliance of the respiratory system (Crs). Faced with a decline in Crs&gt; 10% a new MRA and optimal PEEP setting will be assessed.
Postoperatively, high flow oxygen therapy will be individually indicated by evaluating peripheral oxygen saturation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>STD-O2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intraoperatively ventilated patients with a tidal volume of 5-6 ml / kg of ideal body weightand respiratory rate to maintain normal carbon dioxide, PEEP 5 cmH2O. In this group no recruitment maneuvers or optimal PEEP setting will be performed.
Postoperatively, standard oxygen therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Alveolar recruitment maneuver</intervention_name>
    <description>To start the Alveolar Recruitment Maneuver (ARM) the ventilatory mode will be changed to pressure-controlled mode (PCV) with 20 cmH2O pressure control ventilation. A respiratory rate (RR) of 15 rpm, inspiration: expiration ratio of 1:1, FiO2 of 0.8 and PEEP of 5 cmH2O. The PEEP level will be increased in 5 cmH2O steps every 10 respiratory cycles, increasing to 15 cycles in the last level of PEEP (20 cmH2O), getting an opening pressure at 40 cmH2O airway (duration of the maneuver: 160 sec.)</description>
    <arm_group_label>OLA-iHFNC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PEEP Titration Trial</intervention_name>
    <description>The ventilation mode will then switch back to volume controlled ventilation with the same baseline settings but with 20 cmH2O PEEP level. Then PEEP will be reduced in 2 cmH2O steps each maintained for 5 breaths the level of PEEP with the best (higher) dynamic compliance.</description>
    <arm_group_label>OLA-iHFNC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lung protective ventilation</intervention_name>
    <description>Ventilatory strategy with a PEEP level of 5 cmH2O but without recruitment maneuvers and PEEP titration trial.</description>
    <arm_group_label>STD-O2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Planned thoracic surgery &gt; 2 hours.

          -  Signed informed consent for participation in the study.

        Exclusion Criteria:

          -  Age less than 18 years.

          -  Pregnant or breast-feeding.

          -  Patients with BMI &gt;35.

          -  Syndrome of moderate or severe respiratory distress: PaO2/FiO2 &lt; 200 mmHg.

          -  Heart failure: NYHA IV.

          -  Hemodynamic failure: CI &lt;2.5 L/min/m2 and / or requirements before surgery ionotropic
             support.

          -  Diagnosis or suspicion of intracranial hypertension (intracranial pressure&gt; 15 mmHg).

          -  Mechanical ventilation in the last 15 days.

          -  Presence of pneumothorax. Presence of giant bullae on chest radiography or computed
             tomography (CT).

          -  Patient with preoperatively CPAP.

          -  Participation in another experimental protocol at the time of intervention selection.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Javier Belda, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Anesthesia and Critical Care; Hospital Clinico Universitario</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carlos Ferrando, MD, PhD</last_name>
    <phone>609892732</phone>
    <email>cafeoranestesia@gmail.com</email>
  </overall_contact>
  <results_reference>
    <citation>Ferrando C, Mugarra A, Gutierrez A, Carbonell JA, García M, Soro M, Tusman G, Belda FJ. Setting individualized positive end-expiratory pressure level with a positive end-expiratory pressure decrement trial after a recruitment maneuver improves oxygenation and lung mechanics during one-lung ventilation. Anesth Analg. 2014 Mar;118(3):657-65. doi: 10.1213/ANE.0000000000000105.</citation>
    <PMID>24557111</PMID>
  </results_reference>
  <results_reference>
    <citation>Fleisher LA, Linde-Zwirble WT. Incidence, outcome, and attributable resource use associated with pulmonary and cardiac complications after major small and large bowel procedures. Perioper Med (Lond). 2014 Oct 7;3:7. doi: 10.1186/2047-0525-3-7. eCollection 2014.</citation>
    <PMID>25313335</PMID>
  </results_reference>
  <results_reference>
    <citation>Licker MJ, Widikker I, Robert J, Frey JG, Spiliopoulos A, Ellenberger C, Schweizer A, Tschopp JM. Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends. Ann Thorac Surg. 2006 May;81(5):1830-7.</citation>
    <PMID>16631680</PMID>
  </results_reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 25, 2017</study_first_submitted>
  <study_first_submitted_qc>June 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2017</study_first_posted>
  <last_update_submitted>February 23, 2018</last_update_submitted>
  <last_update_submitted_qc>February 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fundación para la Investigación del Hospital Clínico de Valencia</investigator_affiliation>
    <investigator_full_name>Carlos Ferrando</investigator_full_name>
    <investigator_title>Principal Investigador</investigator_title>
  </responsible_party>
  <keyword>one lung ventilation</keyword>
  <keyword>postoperative pulmonary complication</keyword>
  <keyword>perioperative lung protective ventilation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

